Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert

Seeking Alpha

Amicus Therapeutics Inc. (FOLD)

()

News & PR
Market Currents

Buzz
Twitter: FOLD

Business Intelligence
Transcripts
Events
Key Developments


	52wk high:
	52wk low:
	EPS:
	PE:
	Dividend:
	Yield:
	Market Cap:
	Exchange:

Analysis - Latest Articles

Trial Setback Is Welcome News for Genzyme, But Don't Get Too Excited

Mark Mitchell • Oct 06 • 3 Comments
Sell Genzyme Near Term Due to Continued Manufacturing Challenges

Mark Mitchell • Sep 24 • 2 Comments
Treating Parkinson’s Disease - Investment Opportunities and Challenges

Michael Becker • Aug 03 • 1 Comment
Genzyme's Manufacturing Disruption Highlights Investment Opportunities

Michael Becker • Jul 20 • 4 Comments
Shares of HGSI Up Big in Anticipation of Clinical Trials Update

M. E. Garza • Jul 16 • 1 Comment
Amicus Therapeutics: Amigal Drug Shows Promise

Zacks.com • Jul 07 • Comment!

More articles on FOLD »

Latest Transcript

Amicus Therapeutics, Inc. Q4 2008 Earnings Call Transcript

Wed February 11, 2009

More transcripts on FOLD »

Instablogs

Trial setback is welcome news for Genzyme, but don't get too excited...

Mon October 5, 2009 • Mark Mitchell • 1 Comment
Genzyme update highlights challenges with manufacturing biologics; reiterate near-term SELL

Wed September 23, 2009 • Mark Mitchell • Comment!
Treating Parkinson’s Disease: Investment Opportunities and Challenges

Sun August 2, 2009 • Michael Becker • Comment!

Write a post on FOLD | More Instablogs on FOLD »

Sentiment

What advice would you give to
FOLD?

What's your view of FOLD?

Make sure you include FOLD